NCT07228624
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Secondary Myelofibrosis
Explore clinical trials studying Secondary Myelofibrosis. Study availability and eligibility vary by location and protocol.
31 public trials
7 recruiting studies
Secondary Myelofibrosis trial results
NCT06661915
- Conditions
- Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative Neoplasm, Blood Coagulation Disorders, +19 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT04370301
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Recruiting
Research Platform Myelofibrosis and Anemia
NCT06976918
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
- Locations
-
- Multiple sites all over Germany Multiple Locations, Germany
NCT04282187
- Conditions
- Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +26 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07362225
- Conditions
- Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
- Locations
-
- MPN Research Foundation Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Azienda Ospedaliera Annunziata Cosenza, Calabria, Italy
- Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria, Calabria, Italy
- Università degli Studi di Napoli Federico II U.O.C. di Ematologia e Trapianti di midollo Naples, Campania, Italy
- IRCCS Policlinico Sant'Orsola Bologna, Emilia-Romagna, Italy
Active, not recruiting
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
NCT03118492
- Conditions
- Secondary Myelofibrosis
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
NCT05364762
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +26 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Decitabine in Treating Patients With Myelofibrosis
NCT00095784
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States